Free symposium: Next-Generation Cell Therapy at Janssen Café

Janssen Pharmaceutica, a member of MEDVIA, is offering the free day-long symposium Next-Generation Cell Therapy on 22 June in the Janssen Café in Beerse. A full program of speakers will discuss state-of-the-art research in next-generation cell-based therapies with a specific focus on allogeneic cell therapies and logic-gated chimeric antigen receptors.

Next-Generation Cell Therapy
22 June 8.00-18.00
Janssen Café
Beerse, Belgium

With advancements in technology and research, the next generation in cell therapies is emerging as a promising approach for effective treatment across a wide range of diseases. The symposium also aims to explore the challenges that lie ahead, including manufacturing.

Among the many speakers are:

    • Michael Hudecek, professor of translational CAR-T research at the University of Würzbürg
    • Maria Themeli, assistant professor of cancer biology and immunology at Amsterdam University Medical Center
    • Marc Davies, Vice-president of CAR engineering at the London-based Leucid Bio

 

See the full program and register here!

Share this article

More news on this topic

Better together

and are joining forces in a brand new organization

The members of MEDVIA and flanders.bio have voted to merge their activities in the first half of 2025. With a united voice, we will champion the entire healthtech and biotech ecosystem on the regional, federal and European stage.

The merger allows MEDVIA and flanders.bio to align activities and deliver more powerful support for our collective members. We will achieve greater impact with more dynamic networking opportunities, better directed funding and increased efficiency, sharpening our focus in common areas and drafting strategic roadmaps for Flanders.